摘要目的 了解Akt和磷酸化Akt1(p-Akt1)蛋白在胰腺癌组织中的表达情况,探讨其临床意义.方法 应用免疫组织化学法检测74例胰腺癌组织、10例正常胰腺组织中Akt和p-Akt1蛋白的表达,并分析其与临床病理学特征及预后的关系.结果 Akt和p-Akt1蛋白在胰腺癌组织中的阳性表达率分别为87.8%和83.8%,而正常胰腺组织均阴性表达,相差非常显著(P<0.05).癌组织中Akt和p-Akt1蛋白的表达呈正相关性(r=0.274,P=0.018).Akt和p-Akt1蛋白表达与年龄、性别、肿瘤生长部位、肿瘤大小、病理学分级、淋巴结转移、临床分期及神经浸润均无显著相关性(P>0.05),但p-Akt1蛋白高表达与病理学T分期及TNM分期相关(P=0.002).Akt和p-Akt1蛋白高表达者的中位生存期分别为(16.0±5.7)个月和(23.0±5.5)个月,明显高于低表达者的(9.3±0.2)个月和(11.1±1.8)个月(P分别为0.007和0.004).结论 胰腺癌组织中p-Akt1蛋白表达的程度与良性预后有关,检测胰腺癌中p-Akt1蛋白的表达具有一定的临床意义.

abstractsObjective To investigate the expression of Akt and phosphoryled Akt (p-Akt1) protein in pancreatic carcinoma and to determine the clinical significance. Methods In 74 cases of pancreatic carcinoma and 10 cases of normal pancreatic tissue samples, the expression of Akt and p-Akt1 were detected by immunohistochemical method, and the its relationship with clinicopathologic characteristics and prognosis were analyzed. Results The positive expression rate of Akt and p-Akt1 in pancreatic carcinoma were 87.8% and 83.8% respectively, while there was no expression of Akt and p-Akt1 in normal pancreatic tissue, and the difference was statistically significant (p < 0.05). There was a positive correlation between the expression of Akt and p-Akt1 in pancreatic carcinoma (r =0.274, P =0. 018). The expression of Akt and p-Akt1 was not significantly associated with the age, sex, location, size, pathology stages, lymph nodes metastasis, clinical stages and nerve invasion of the tumor (P >0.05). But the higher expression of p-Akt1 was associated with T stages and TNM staging (p =0. 002). Patients with high intensity of Akt and p-Akt1 expression showed a significantly longer median survival time [(16.0 ± 5.7) month and (23.0 ± 5.5) month, respectively]than those with low intensity expression [(9.3 ± 0.2) month and (11.1 ± 1.8) month (P = 0. 007 and P = 0.004) respectively]. Conclusions p-Akt1 expression is a significant positive prognostic factor for pancreaticcarcinoma and detection of p-Akt1 expression may be of clinical value.